je.st
news
Canaccord Genuity Reaffirms Buy Rating for Regeneron Pharmaceuticals
2015-08-30 19:41:11| Biotech - Topix.net
's stock had its "buy" rating restated by research analysts at Canaccord Genuity in a research report issued on Wednesday, Market Beat Ratings reports. They presently have a $700.00 price target on the biopharmaceutical company's stock, up from their previous price target of $600.00.
Tags: buy
rating
pharmaceuticals
reaffirms
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||